Ghost Tree Capital, LLC Bellus Health Inc. Transaction History

Ghost Tree Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$5.56 - $7.99 $2.5 Million - $3.6 Million	-450,000 Closed	0 $0
Q4 2021 Feb 16, 2022	BUY	$5.26 - $8.3 $263,000 - $415,000	50,000 Added 12.5%	450,000 $3.62 Million
Q3 2021 Nov 15, 2021	BUY	$2.7 - $6.64 $1.08 Million - $2.66 Million	400,000 New	400,000 $2.46 Million

128K

Ticker BLU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,793,000
Description
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.